RayzeBio
Latest round
- Series D
Last raised
- Aug 2022
Total raised
- $419M
Investors
- 22
About RayzeBio
RayzeBio, Inc.Founded in 2020 and headquartered in San Diego, US, RayzeBio, Inc. specializes in precision radiopharmaceutical therapies. RayzeBio was co-founded by Aaron Kantoff, Aron Knickerbocker, and Deborah Charych, with Ken Song serving as the CEO.RayzeBio specializes in precision radiopharmaceutical therapies (RPTs), emphasizing the innovative use of actinium-225 (Ac225). Their offerings aim to transform cancer treatment by providing targeted therapies that utilize alpha-emitting isotopes, thus minimizing side effects associated with traditional treatments. The company's products are tailored to meet the needs of oncology professionals and patients, enhancing therapeutic outcomes and quality of life.RayzeBio generates revenue primarily from direct sales of its precision radiopharmaceutical therapies to hospitals and specialized cancer treatment facilities. The sales transactions are structured as B2B engagements, where healthcare providers purchase these specialized products. The company’s pricing reflects the complexity and innovation of its actinium-based therapies, ensuring clients obtain access to advanced cancer treatment solutions.In September 2023, RayzeBio, Inc.28 million shares at USD 18 per share on Nasdaq. RayzeBio is focused on launching new products and is pursuing expansion into additional geographic markets, although specific markets and timelines have not been disclosed.
Who invested in RayzeBio
22 investors across 4 rounds
See all investors in RayzeBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about RayzeBio
Who invested in RayzeBio?
RayzeBio has 22 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has RayzeBio raised?
RayzeBio has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did RayzeBio last raise money?
RayzeBio's most recent round on record is a Series D, in Aug 2022.
What does RayzeBio do?
RayzeBio is a biotechnology company.
Where is RayzeBio headquartered?
RayzeBio is headquartered in San Diego, US.
Which VCs invest in companies like RayzeBio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at RayzeBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like RayzeBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.